Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo ...

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...

Research shows that live musical performances in hospitals benefit the physical and emotional well-being of patients, their ...

Overview: The demand for programming skills in 2026 centres around versatility, performance, and scalability as companies ramp up AI, cloud, and web services.La ...

State auditors flagged mismanagement and political influence in AICS and AKAP, yet the bicameral committee still approved ...

Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program.

Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for ...

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...

As the global population ages, 2025 has delivered a remarkable wave of new research aimed at supporting healthier brains in ...

Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2 -- Affecting up to 100,000 people in the U.S. and up to 5.6 ...

ESET researchers provide a comprehensive analysis and assessment of a critical severity vulnerability with low likelihood of ...

Cybersecurity protection is a C-suite issue that is so fast-changing and technical, it’s hard for CEOs to properly manage.